Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Johnson

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Journal of Rehabilitation Research and Development|April 17, 2007
Preamputation evaluation of limb perfusion with laser Doppler imaging and transcutaneous gasesStephen F Figoni, Oscar U Scremin, Charles F Kunkel, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2007
Disruption of Golgi processing by 2-phenyl benzimidazole analogs blocks cell proliferation and slows tumor growthShirley Cruz Lio, Jessica Johnson, Arka Chatterjee, et al.
Epilepsia|June 13, 2018
Laser ablation for mesial temporal lobe epilepsy: Surgical and cognitive outcomes with and without mesial temporal sclerosisCristian Donos, Joshua Breier, Elliott Friedman, et al.
Ebiomedicine|February 13, 2019
Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC)Daria V Ilatovskaya, Vladislav Levchenko, Tengis S Pavlov, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|October 23, 2024
Resolving the Size and Charge of Small Particles: A Predictive Model of Nanopore MechanicsSamuel Bearden, Tigran M Abramyan, Dmitry Gil, et al.
BMC Cancer|July 28, 2011
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyDusan Kotasek, Niall Tebbutt, Jayesh Desai, et al.
Journal of Clinical Pharmacology|September 27, 2016
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic ImpairmentJohn P Gibbs, J Greg Slatter, Ogo Egbuna, et al.
Substance Use & Addiction Journal|August 3, 2024
Identifying Patients at Risk for Alcohol-Exposed Pregnancies: The Importance of Addressing Multiple Risk FactorsBonnie G McRee, Bridget L Hanson, Janice Vendetti, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Non-additive effects of schizophrenia risk genes reflect convergent downstream functionPj Michael Deans, Carina Seah, Jessica Johnson, et al.
EJNMMI Research|May 17, 2023
[<sup>99m</sup>Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expressionMuhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Journal of Rehabilitation Research and Development|April 17, 2007
Preamputation evaluation of limb perfusion with laser Doppler imaging and transcutaneous gasesStephen F Figoni, Oscar U Scremin, Charles F Kunkel, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2007
Disruption of Golgi processing by 2-phenyl benzimidazole analogs blocks cell proliferation and slows tumor growthShirley Cruz Lio, Jessica Johnson, Arka Chatterjee, et al.
Epilepsia|June 13, 2018
Laser ablation for mesial temporal lobe epilepsy: Surgical and cognitive outcomes with and without mesial temporal sclerosisCristian Donos, Joshua Breier, Elliott Friedman, et al.
Ebiomedicine|February 13, 2019
Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC)Daria V Ilatovskaya, Vladislav Levchenko, Tengis S Pavlov, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|October 23, 2024
Resolving the Size and Charge of Small Particles: A Predictive Model of Nanopore MechanicsSamuel Bearden, Tigran M Abramyan, Dmitry Gil, et al.
BMC Cancer|July 28, 2011
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyDusan Kotasek, Niall Tebbutt, Jayesh Desai, et al.
Journal of Clinical Pharmacology|September 27, 2016
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic ImpairmentJohn P Gibbs, J Greg Slatter, Ogo Egbuna, et al.
Substance Use & Addiction Journal|August 3, 2024
Identifying Patients at Risk for Alcohol-Exposed Pregnancies: The Importance of Addressing Multiple Risk FactorsBonnie G McRee, Bridget L Hanson, Janice Vendetti, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Non-additive effects of schizophrenia risk genes reflect convergent downstream functionPj Michael Deans, Carina Seah, Jessica Johnson, et al.
EJNMMI Research|May 17, 2023
[<sup>99m</sup>Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expressionMuhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, et al.
Pageof 14